Total antioxidant and glutathione levels have been shown to be lower within the plasma of non-medicated, medicated, first-episode and chronic schizophrenia patients ( Results from in vivo MRS studies of glutamate/glutamine concentrations in schizophrenia, whilst inconsistent, have highlighted that sub-grouping patients on residual schizophrenia (long-term negative symptoms/impairments) revealed reduced, highly correlated, GSH, glutamate and glutamine concentrations in the ACC ( It has been suggested that, in schizophrenia, redox dysregulation and subsequent oxidative stress may be limited to a specific subgroup representing ~1 third of patients ( Genetic Studies Genome wide association studies have shown an association between gene polymorphisms for oxidative stress and schizophrenia ( Animal Models Higher levels of reactive species within mitochondria have been found in the brains of ketamine-induced rat models of schizophrenia compared to wild-type controls ( Evidence of redox dysregulation is seen in other common neurodevelopmental animal models of schizophrenia
Effect and mechanisms of Polygonatum kingianum (polygonati rhizome) on wound healing in diabetic rats
A favorite among biohackers and longevity experts for optimizing health and slowing the effects of aging
While ongoing research underscores its potential as a breakthrough in regenerative therapy, further human trials are essential to fully elucidate its long-term safety, efficacy, and clinical applications.
